Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Remin Pro** is a water-based, topical remineralizing protective cream designed for the management of dentin hypersensitivity and the restoration of dental enamel mineral content. Developed and manufactured by **VOCO**, the formulation integrates three primary active components: **hydroxyapatite**, **fluoride** (1450 ppm sodium fluoride), and **xylitol**. Hydroxyapatite serves to fill superficial enamel defects and occlude open dentinal tubules, effectively reducing sensitivity to external stimuli. Fluoride facilitates the remineralization process by promoting the formation of fluorapatite, which enhances the acid resistance of the tooth surface. Xylitol acts as an antibacterial agent by inhibiting the growth and metabolism of cariogenic bacteria such as *Streptococcus mutans*. A specialized variant, **Remin Pro Forte**, includes additional natural extracts—ginger and curcuma—for their antibacterial and anti-inflammatory properties. The product is widely used for treating post-orthodontic white spot lesions (WSLs), maintaining shade stability after bleaching, and preventing caries in high-risk patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Remin Pro.